-
1
-
-
18344381087
-
Chronic hepatitis C and genotyping: The clinical significance of determining HCV genotypes
-
Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther. 2005;10(1):1-11.
-
(2005)
Antivir Ther
, vol.10
, Issue.1
, pp. 1-11
-
-
Hnatyszyn, H.J.1
-
2
-
-
76149141825
-
Hepatitis C virus: Molecular biology & current therapeutic options
-
Sharma SD. Hepatitis C virus: molecular biology & current therapeutic options. Indian J Med Res. 2010;131:17-34.
-
(2010)
Indian J Med Res
, vol.131
, pp. 17-34
-
-
Sharma, S.D.1
-
3
-
-
26444432835
-
Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6
-
Nguyen MH, Keeffe EB. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol. 2005;3(10 Suppl 2):S97-S101.
-
(2005)
Clin Gastroenterol Hepatol
, vol.3
, Issue.10 SUPPL 2
-
-
Nguyen, M.H.1
Keeffe, E.B.2
-
4
-
-
42249110672
-
Hepatitis C genotype 4: What we know and what we don't yet know
-
Kamal SM, Nasser IA. Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology. 2008;47(4):1371- 83.
-
(2008)
Hepatology
, vol.47
, Issue.4
, pp. 1371-1383
-
-
Kamal, S.M.1
Nasser, I.A.2
-
5
-
-
21844457406
-
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study
-
Payan C, Roudot-Thoraval F, Marcellin P, et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat. 2005;12(4):405-13.
-
(2005)
J Viral Hepat
, vol.12
, Issue.4
, pp. 405-413
-
-
Payan, C.1
Roudot-Thoraval, F.2
Marcellin, P.3
-
6
-
-
11444267247
-
Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France
-
Nicot F, Legrand-Abravanel F, Sandres-Saune K, et al. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J Gen Virol. 2005;86(Pt 1):107-14.
-
(2005)
J Gen Virol
, vol.86
, Issue.PT 1
, pp. 107-114
-
-
Nicot, F.1
Legrand-Abravanel, F.2
Sandres-Saune, K.3
-
7
-
-
33644875745
-
Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates
-
Katsoulidou A, Sypsa V, Tassopoulos NC, et al. Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat. 2006;13(1):19-27.
-
(2006)
J Viral Hepat
, vol.13
, Issue.1
, pp. 19-27
-
-
Katsoulidou, A.1
Sypsa, V.2
Tassopoulos, N.C.3
-
8
-
-
33749583068
-
High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): Phylogenetic and epidemiological analyses
-
Fernandez-Arcas N, Lopez-Siles J, Trapero S, et al. High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses. J Med Virol. 2006;78(11):1429-35.
-
(2006)
J Med Virol
, vol.78
, Issue.11
, pp. 1429-1435
-
-
Fernandez-Arcas, N.1
Lopez-Siles, J.2
Trapero, S.3
-
9
-
-
1842555459
-
Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: Relation to progression of liver fibrosis
-
Kamal SM, Graham CS, He Q, et al. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J Infect Dis. 2004;189(7):1140-50.
-
(2004)
J Infect Dis
, vol.189
, Issue.7
, pp. 1140-1150
-
-
Kamal, S.M.1
Graham, C.S.2
He, Q.3
-
10
-
-
33645986652
-
Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis
-
Kamal SM, Turner B, He Q, et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology. 2006;43(4):771-9.
-
(2006)
Hepatology
, vol.43
, Issue.4
, pp. 771-779
-
-
Kamal, S.M.1
Turner, B.2
He, Q.3
-
11
-
-
34250625319
-
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection
-
Roulot D, Bourcier V, Grando V, et al. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat. 2007;14(7):460-7.
-
(2007)
J Viral Hepat
, vol.14
, Issue.7
, pp. 460-467
-
-
Roulot, D.1
Bourcier, V.2
Grando, V.3
-
12
-
-
0033930712
-
Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis
-
Koshy A, Marcellin P, Martinot M, Madda JP. Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis. Liver. 2000;20(4):335-9.
-
(2000)
Liver
, vol.20
, Issue.4
, pp. 335-339
-
-
Koshy, A.1
Marcellin, P.2
Martinot, M.3
Madda, J.P.4
-
13
-
-
0034674034
-
Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha
-
Zylberberg H, Chaix ML, Brechot C. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Ann Intern Med. 2000;132(10):845-6.
-
(2000)
Ann Intern Med
, vol.132
, Issue.10
, pp. 845-846
-
-
Zylberberg, H.1
Chaix, M.L.2
Brechot, C.3
-
14
-
-
0033962163
-
Interferon therapy in patients with chronic hepatitis C and schistosomiasis
-
Kamal SM, Madwar MA, Peters T, Fawzy R, Rasenack J. Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J Hepatol. 2000;32(1):172-4.
-
(2000)
J Hepatol
, vol.32
, Issue.1
, pp. 172-174
-
-
Kamal, S.M.1
Madwar, M.A.2
Peters, T.3
Fawzy, R.4
Rasenack, J.5
-
15
-
-
21144449073
-
Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: Impact of treatment duration and viral kinetics on sustained virological response
-
Kamal SM, El Tawil AA, Nakano T, et al. Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response. Gut. 2005;54(6):858-66.
-
(2005)
Gut
, vol.54
, Issue.6
, pp. 858-866
-
-
Kamal, S.M.1
El Tawil, A.A.2
Nakano, T.3
-
16
-
-
4544344295
-
Peginterferon alfa- 2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
-
Hasan F, Asker H, Al-Khaldi J, et al. Peginterferon alfa- 2b plus ribavirin for the treatment of chronic hepatitis C genotype 4. Am J Gastroenterol. 2004;99(9):1733-7.
-
(2004)
Am J Gastroenterol
, vol.99
, Issue.9
, pp. 1733-1737
-
-
Hasan, F.1
Asker, H.2
Al-Khaldi, J.3
-
17
-
-
19944409281
-
Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4
-
Alfaleh FZ, Hadad Q, Khuroo MS, et al. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4. Liver Int. 2004;24(6):568-74.
-
(2004)
Liver Int
, vol.24
, Issue.6
, pp. 568-574
-
-
Alfaleh, F.Z.1
Hadad, Q.2
Khuroo, M.S.3
-
18
-
-
32444449114
-
Response of hepatitis C genotype-4 naive patients to 24 weeks of Peginterferon- alpha2b/ribavirin or induction-dose interferonalpha2b/ribavirin/amantadine: A non-randomized controlled study
-
El-Zayadi AR, Attia M, Barakat EM, et al. Response of hepatitis C genotype-4 naive patients to 24 weeks of Peginterferon- alpha2b/ribavirin or induction-dose interferonalpha2b/ribavirin/amantadine: a non-randomized controlled study. Am J Gastroenterol. 2005;100(11):2447-52.
-
(2005)
Am J Gastroenterol
, vol.100
, Issue.11
, pp. 2447-2452
-
-
El-Zayadi, A.R.1
Attia, M.2
Barakat, E.M.3
-
19
-
-
37749046123
-
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response
-
Kamal SM, El Kamary SS, Shardell MD, et al. Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response. Hepatology. 2007;46(6):1732-40.
-
(2007)
Hepatology
, vol.46
, Issue.6
, pp. 1732-1740
-
-
Kamal, S.M.1
El Kamary, S.S.2
Shardell, M.D.3
-
20
-
-
33750100192
-
Treatment of hepatitis C virus genotype 4 with peginterferon alfa- 2a: Impact of bilharziasis and fibrosis stage
-
Derbala MF, Al Kaabi SR, El Dweik NZ, et al. Treatment of hepatitis C virus genotype 4 with peginterferon alfa- 2a: impact of bilharziasis and fibrosis stage. World J Gastroenterol. 2006;12(35):5692-8.
-
(2006)
World J Gastroenterol
, vol.12
, Issue.35
, pp. 5692-5698
-
-
Derbala, M.F.1
Al Kaabi, S.R.2
El Dweik, N.Z.3
-
21
-
-
0346727453
-
Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin
-
Diago M, Hassanein T, Rodes J, Ackrill AM, Sedarati F. Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin. Ann Intern Med. 2004;140(1):72-3.
-
(2004)
Ann Intern Med
, vol.140
, Issue.1
, pp. 72-73
-
-
Diago, M.1
Hassanein, T.2
Rodes, J.3
Ackrill, A.M.4
Sedarati, F.5
-
22
-
-
34547738021
-
Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: Experience from a spanish center
-
Trapero-Marugan M, Moreno-Monteagudo JA, Garcia- Buey L, et al. Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: experience from a spanish center. J Chemother. 2007;19(4):423-7.
-
(2007)
J Chemother
, vol.19
, Issue.4
, pp. 423-427
-
-
Trapero-Marugan, M.1
Moreno-Monteagudo, J.A.2
Garcia-Buey, L.3
-
23
-
-
23044510877
-
Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
-
Legrand-Abravanel F, Nicot F, Boulestin A, et al. Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection. J Med Virol. 2005;77(1):66-9.
-
(2005)
J Med Virol
, vol.77
, Issue.1
, pp. 66-69
-
-
Legrand-Abravanel, F.1
Nicot, F.2
Boulestin, A.3
-
24
-
-
18344364551
-
Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4
-
Soriano V, Nunez M, Sanchez-Conde M, et al. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4. Antivir Ther. 2005;10(1):167-70.
-
(2005)
Antivir Ther
, vol.10
, Issue.1
, pp. 167-170
-
-
Soriano, V.1
Nunez, M.2
Sanchez-Conde, M.3
-
25
-
-
48749099989
-
Peginterferon alfa- 2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response
-
Ferenci P, Laferl H, Scherzer TM, et al. Peginterferon alfa- 2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response. Gastroenterology. 2008;135(2):451-8.
-
(2008)
Gastroenterology
, vol.135
, Issue.2
, pp. 451-458
-
-
Ferenci, P.1
Laferl, H.2
Scherzer, T.M.3
-
26
-
-
70349234307
-
Differential viral kinetics in treated genotype 4 chronic hepatitis C patients according to ethnicity
-
Elefsiniotis IS, Pavlidis C, Dimitroulopoulos D, et al. Differential viral kinetics in treated genotype 4 chronic hepatitis C patients according to ethnicity. J Viral Hepat. 2009;16(10):738-42.
-
(2009)
J Viral Hepat
, vol.16
, Issue.10
, pp. 738-742
-
-
Elefsiniotis, I.S.1
Pavlidis, C.2
Dimitroulopoulos, D.3
-
27
-
-
77950624760
-
The neglected hepatitis C virus genotypes 4, 5 and 6: An international consensus report
-
Antaki N, Craxi A, Kamal S, et al. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. Liver Int. 2010;30(3):342-55.
-
(2010)
Liver Int
, vol.30
, Issue.3
, pp. 342-355
-
-
Antaki, N.1
Craxi, A.2
Kamal, S.3
-
28
-
-
85061109161
-
MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients
-
Shaker O, Ahmed A, Doss W, Abdel-Hamid M. MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients. J Viral Hepat. 2009.
-
(2009)
J Viral Hepat
-
-
Shaker, O.1
Ahmed, A.2
Doss, W.3
Abdel-Hamid, M.4
-
29
-
-
33847379731
-
Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4
-
Zekri AR, El-Din HM, Bahnassy AA, et al. Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4. Virol J. 2007;4:16.
-
(2007)
Virol J
, vol.4
, pp. 16
-
-
Zekri, A.R.1
El-Din, H.M.2
Bahnassy, A.A.3
|